- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pulmonx Corp (LUNG)
Pulmonx Corp stock price live, this page displays NASDAQ LUNG stock exchange data. View the LUNG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pulmonx Corp real time stock price chart below.
What Is the Pulmonx Corp Stock Price Today?
The Pulmonx Corp stock price today is 1.89.
What Is the Stock Symbol for Pulmonx Corp?
The stock symbol for Pulmonx Corp is ""LUNG.""
What Stock Exchange Does Pulmonx Corp Trade On?
Pulmonx Corp is listed and trades on the NASDAQ stock exchange.
Is Pulmonx Corp a Good Stock to Buy?
Determining whether Pulmonx Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LUNG quote. (ISIN: US7458481014)
What Is the Pulmonx Corp Stock Price Today?
The Pulmonx Corp stock price today is 1.89.
What Is the Stock Symbol for Pulmonx Corp?
The stock symbol for Pulmonx Corp is ""LUNG.""
What Stock Exchange Does Pulmonx Corp Trade On?
Pulmonx Corp is listed and trades on the NASDAQ stock exchange.
Is Pulmonx Corp a Good Stock to Buy?
Determining whether Pulmonx Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LUNG quote. (ISIN: US7458481014)
Fair Value
An estimate of a Pulmonx's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.75
1.94
52 wk Range
1.31
9.37
LUNG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Pulmonx's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.751.94
52 wk Range
1.319.37
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LUNG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Pulmonx's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
5.75
Upside
+204.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 13G Pulmonx Corporation For: 13 November
- Investing.com
- Form 13G Pulmonx Corporation For: 13 November
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Pulmonx Corp Company Profile
Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Pulmonx Corp Earnings Call Summary for Q2/2025
- Q2 2025 revenue beat expectations at $23.9M, up 15% YoY; net loss of $0.38 per share, better than forecast
- International revenue surged 32%, U.S. revenue grew 6%; stock price rose 1.94% post-earnings
- 2025 revenue guidance revised to $90-92M, indicating 7-10% growth; focus on 'acquire, test, and treat' strategy
- CEO highlights strong international performance, emphasizes long-term growth potential despite U.S. challenges
- Risks include slower U.S. growth, capacity constraints, market competition, and potential regulatory delays
Last Updated: 30/07/2025, 22:58
Read Full TranscriptCompare LUNG to Peers and Sector
Metrics to compare | LUNG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLUNGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −2.5x | −0.6x | |
PEG Ratio | −0.34 | −0.14 | 0.00 | |
Price/Book | 1.3x | 4.7x | 2.6x | |
Price / LTM Sales | 0.9x | 6.0x | 3.3x | |
Upside (Analyst Target) | 134.4% | 65.8% | 41.8% | |
Fair Value Upside | Unlock | 5.7% | 6.2% | Unlock |
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 5.75
(+204.23% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.34 / -0.42
Revenue / Forecast
21.50M / 20.78M
People Also Watch
FAQ
What Is the Pulmonx (LUNG) Premarket Price Today?
The Pulmonx (LUNG) premarket price is 1.79. Premarket price change units: 0.04. Premarket percentage change: 2.29%. Premarket volume: 900.00. Current date: 03 Dec 2025. Previous close: 1.75
What Stock Exchange Does Pulmonx Trade On?
Pulmonx is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Pulmonx?
The stock symbol for Pulmonx is "LUNG."
What Is the Pulmonx (LUNG) Afterhours Price Today? (Afterhours variable test: 1.81) Current Date: 03 Dec 2025
After hours price: 1.81. After hours price change (units): -0.08. Price change percentage: -4.46%
What Is the Pulmonx Market Cap?
As of today, Pulmonx market cap is 79.19M.
What Is Pulmonx's Earnings Per Share (TTM)?
The Pulmonx EPS (TTM) is -1.41.
When Is the Next Pulmonx Earnings Date?
Pulmonx will release its next earnings report on 24 Feb 2026.
From a Technical Analysis Perspective, Is LUNG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Pulmonx Stock Split?
Pulmonx has split 0 times.
How Many Employees Does Pulmonx Have?
Pulmonx has 291 employees.
What is the current trading status of Pulmonx (LUNG)?
As of 03 Dec 2025, Pulmonx (LUNG) is trading at a price of 1.89, with a previous close of 1.75. The stock has fluctuated within a day range of 1.75 to 1.94, while its 52-week range spans from 1.31 to 9.37.
What Is Pulmonx (LUNG) Price Target According to Analysts?
The average 12-month price target for Pulmonx is USD5.75, with a high estimate of USD14 and a low estimate of USD2.5. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +204.23% Upside potential.
What Is the LUNG Premarket Price?
LUNG's last pre-market stock price is 1.79. The pre-market share volume is 900.00, and the stock has decreased by 0.04, or 2.29%.
What Is the LUNG After Hours Price?
LUNG's last after hours stock price is 1.81, the stock has decreased by -0.08, or -4.46%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.